|
2025
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for human use. |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of auto-immune and inflammato... |
|
2024
|
Invention
|
Method of treating depression using seltorexant.
A method of treating an orexin-2 mediated disor... |
|
|
Invention
|
Intrabodies targeting intracellular tau. The present invention provides a method of binding intra... |
|
|
Invention
|
Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators.
Substituted Py... |
|
|
Invention
|
(r) -n-ethyl-5-fluoro-n-isopropyl-2- ( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhe... |
|
|
Invention
|
Imidazopyridazine il-17 inhibitor compounds.
The present application discloses compounds having ... |
|
|
Invention
|
Immunoglobulins and uses thereof.
The present invention relates to a monoclonal antibody platfor... |
|
|
Invention
|
Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria. The present in... |
|
|
Invention
|
Smarca2 inhibitors useful for the treatment of smarca4 deficient cancers. The invention relates t... |
|
|
Invention
|
Interleukin-23 receptor antagonist for use in the treatment of ulcerative colitis. The present di... |
|
|
Invention
|
Compounds and uses thereof.
The present invention features compounds useful in the treatment of ... |
|
|
Invention
|
Snca sirna and uses thereof. Provided herein are small interfering ribonucleic acid (siRNA) agent... |
|
|
Invention
|
Plasma assay for detecting cns-derived tau peptides. Provided herein are methods and assays for d... |
|
|
Invention
|
Combination therapy for prostate cancer.
Provided are methods and compositions, for treating pro... |
|
|
Invention
|
Modified oligonucleotides and methods of use.
Modified oligonucleotides comprising modifications... |
|
|
Invention
|
Combination of niraparib and abiraterone for use in the treatment of metastatic castration-resist... |
|
|
Invention
|
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic gl... |
|
|
Invention
|
Combination products of at least three antibiotics comprising bedaquiline, pretomanid or delamani... |
|
|
Invention
|
Smarca2 inhibitor useful for the treatment of smarca4 deficient cancers. The invention relates to... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase and methods of their use.
The present disclosure is direc... |
|
|
Invention
|
Malt1 inhibitors. Disclosed are compounds of formula (I), compositions and methods for treating o... |
|
|
Invention
|
Method of treating depression using seltorexant. A method of treating an orexin-2 mediated disord... |
|
|
Invention
|
Esketamine for the treatment of depression.
The present invention provides methods for treating ... |
|
|
Invention
|
Treatment of locally advanced or metastatic urothelial carcinoma with erdafinitib. The present in... |
|
|
Invention
|
Monoacylglycerol lipase modulators.
Bridged compounds of Formula (I) and Formula (II), pharmaceu... |
|
|
Invention
|
Pre-filled syringe with optimized stopper placement.
A pre-filled syringe includes a barrel with... |
|
|
Invention
|
Antibacterial compounds. The present invention relates to the following compounds (I), wherein th... |
|
|
Invention
|
Use of milvexian for treating or preventing adverse cerebrovascular events or adverse cardiovascu... |
|
|
Invention
|
Use of milvexian in the treatment and prevention of thrombotic conditions in patients with atrial... |
|
|
Invention
|
Use of milvexian in the treatment and prevention of thrombotic conditions in patients with cardio... |
|
|
Invention
|
Combination of a menin-ll1 inhibitor, a dna intercalating agent and a pyrimidine analogue to trea... |
|
|
Invention
|
Lactam-containing imidazopyridazine il-17 inhibitor compounds. The present application discloses ... |
|
|
Invention
|
Esketamine for use in the treatment of depression. The present invention is directed to methods a... |
|
|
P/S
|
Medical apparatus and instruments for use in surgery;
surgical apparatus and instruments. |
|
|
P/S
|
Medical apparatus and instruments for use in surgery;
surgical apparatus and instruments; trocar... |
|
|
Invention
|
Gene therapy vectors for use in parkinson's disease.
Disclosed herein are recombinant gene thera... |
|
2023
|
Invention
|
1,6-naphthridine compounds as smarca2 inhibitors useful for the treatment of smarca4 deficient ca... |
|
|
Invention
|
Assessing functional vision of a patient based on patient interaction with a virtual environment.... |
|
|
Invention
|
Multispecific antibodies and uses thereof.
Provided are multispecific antibodies or antigen bind... |
|
2022
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of viral diseases, auto-immun... |
|
|
Invention
|
Macrocyclic 2-amino-but-3-enamides as inhibitors of mcl-1.
The present invention relates to phar... |
|
|
Invention
|
Benzimidazoles as modulators of il-17.
The present application discloses compounds having the fo... |
|
|
Invention
|
Benzimidazoles as modulators of il-17.
The present application discloses compounds of Formula (I... |
|
|
Invention
|
Milvexian for prevention and treatment of thromboembolic disorders.
The factor Xia inhibitor mil... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer for
human use. |
|
|
Invention
|
Combination therapies for metastatic castration-resistant prostate cancer.
Provided herein are t... |
|
|
P/S
|
Vaccines. |
|
|
Invention
|
Treatment of metastatic castration-resistant prostate cancer with niraparib.
The present inventi... |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of oncological diseases and d... |
|
|
Invention
|
Substituted spiro derivatives.
The present invention relates to pharmaceutical agents useful for... |
|
2021
|
Invention
|
Methods for treating depression.
The disclosure is directed to methods of treating depression in... |
